Literature DB >> 18253909

Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids.

A M Schoepfer1, J Gschossmann, U Scheurer, F Seibold, A Straumann.   

Abstract

Strictures are a frequent complication of eosinophilic esophagitis. The efficacy and safety of topical corticosteroids and of dilation of eosinophilic esophagitis-associated strictures have not yet been thoroughly clarified. We present a retrospective analysis of 10 adult patients with eosinophilic esophagitis who had symptomatic esophageal stenosis that was unresponsive to topical corticosteroids, and who were treated using bougienage. Eight patients had one single stricture, one patient had two, and another had three strictures; mean stricture length was 2.1 cm (range 1 - 6 cm). Bougienage led to prompt symptom relief. Apart from transient postprocedural odynophagia, no severe complications occurred. During the follow-up (mean 6 months; range 2 - 11 months), all patients enjoyed sustained treatment response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253909     DOI: 10.1055/s-2007-995345

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  28 in total

Review 1.  A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis.

Authors:  John William Jacobs; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

Review 2.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 3.  Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.

Authors:  Bharati Kochar; Evan S Dellon
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-12       Impact factor: 3.869

Review 4.  Management of pediatric eosinophilic esophagitis: an update.

Authors:  Seema Khan
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

Review 5.  Eosinophilic esophagitis.

Authors:  Fouad J Moawad; Ganesh R Veerappan; Roy K Wong
Journal:  Dig Dis Sci       Date:  2009-06-25       Impact factor: 3.199

Review 6.  White Paper AGA: Drug Development for Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Stuart Spechler; Glenn Furuta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-22       Impact factor: 11.382

Review 7.  Eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2012-12-27       Impact factor: 3.806

8.  Current hurdles in the management of eosinophilic oesophagitis: the next steps.

Authors:  Stephen Ea Attwood; Michael Sj Wilson
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

9.  Emerging therapeutic options for eosinophilic esophagitis.

Authors:  Timothy Dougherty; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

10.  Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis.

Authors:  Cary C Cotton; Daniel Erim; Swathi Eluri; Sarah H Palmer; Daniel J Green; W Asher Wolf; Thomas M Runge; Stephanie Wheeler; Nicholas J Shaheen; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.